| Line item | 2025-12-31 FY | 2024-12-31 FY | 2024-06-30 FY | 2023-06-30 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $13.06M | $4.43M | $7.31M | $11.11M | – | – |
| R&D | $10.25M | $2.86M | $4.11M | $10.45M | – | – |
| SG&A | $2.81M | $1.57M | $3.20M | $663.19K | – | – |
| Operating Income | -$13.06M | -$4.43M | -$7.31M | -$11.11M | -$1.57M | -$249.15K |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $838.00 | $63.00 | $1.63K | – | $80.65K | $0.00 |
| Net Income | -$13.06M | -$4.43M | -$7.31M | -$11.11M | -$996.10K | -$247.72K |
| EPS (basic) | -0.3500 | -0.1200 | -0.2700 | -36.3500 | – | – |
| EPS (diluted) | -0.3500 | -0.1200 | -0.2700 | -36.3500 | – | – |
| Shares (diluted) | $36.82M | $36.52M | $27.10M | $305.75K | – | $1.18M |